Raymond James Financial Inc Glaukos Corp Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Glaukos Corp stock. As of the latest transaction made, Raymond James Financial Inc holds 112,771 shares of GKOS stock, worth $10.1 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
112,771Holding current value
$10.1 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding GKOS
# of Institutions
346Shares Held
48MCall Options Held
282KPut Options Held
401K-
Black Rock Inc. New York, NY8.04MShares$721 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.97MShares$536 Million0.02% of portfolio
-
State Street Corp Boston, MA2.06MShares$185 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.93MShares$173 Million0.08% of portfolio
-
Invesco Ltd. Atlanta, GA1.46MShares$131 Million0.04% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $4.27B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...